Factors mediating type 2 diabetes remission and relapse after gastric bypass surgery
Journal of the American College of Surgeons Nov 05, 2019
Pessoa BM, Browning MG, Mazzini GS, et al. - Via performing a retrospective review of 621 patients with type 2 diabetes (T2D) who underwent gastric bypass (RYGB) between 1993 and 2017, researchers sought to determine the factors linked with T2D remission and relapse after RYGB. Medication discontinuation and/or HbA1c < 6.5% T2D defined remission; recurrent medication use and/or HbA1c ≥ 6.5% defined relapse. Findings of this longitudinal retrospective analysis revealed that T2D remission and relapse following RYGB are influenced by preoperative insulin use and age, one-year weight loss, and regain. For improving the rates and durability of T2D remission, they emphasize referring patients at a younger age, before insulin is needed, and optimizing both weight loss and weight maintenance after RYGB.Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
55 lakhs+ doctors trust M3 globally
Unlimited access to original articles by experts
Secure: we never sell your data
Signing up takes less than 2 mins